John Hussman's ADMA Position Overview
John Hussman (via Hussman Strategic Advisors, Inc.) currently holds 63.0K shares of ADMA Biologics, Inc. (ADMA) worth $0, representing 0.00% of the portfolio. First purchased in 2020-Q3, this long-term strategic position has been held for 21 quarters.
Based on 13F filings, John Hussman has maintained a strategic position in ADMA, demonstrating sustained confidence in this investment. Largest addition occurred in Q1 2025, adding 23.0K shares. Largest reduction occurred in Q2 2025, reducing 42.0K shares.
Analysis based on 13F filings available since 2013 Q2
John Hussman's ADMA Biologics (ADMA) Holding Value Over Time
Track share changes against reported price movement
Quarterly ADMA Biologics (ADMA) Trades by John Hussman
| Period | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q3 2020 | +100,000 | New Buy | 100,000 | $2.39 |
| Q4 2020 | -18,000 | Reduce 18.00% | 82,000 | $1.95 |
| Q1 2021 | -82,000 | Sold Out | 82,000 | $0.00 |
| Q1 2025 | +105,000 | New Buy | 105,000 | $19.84 |
| Q2 2025 | -42,000 | Reduce 40.00% | 63,000 | $18.21 |
| Q3 2025 | -63,000 | Sold Out | 63,000 | $0.00 |
John Hussman's ADMA Biologics Investment FAQs
John Hussman first purchased ADMA Biologics, Inc. (ADMA) in Q3 2020, acquiring 100,000 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
John Hussman has held ADMA Biologics, Inc. (ADMA) for 21 quarters since Q3 2020. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
John Hussman's largest addition to ADMA Biologics, Inc. (ADMA) was in Q1 2025, adding 105,000 shares worth $2.08 M. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
According to the latest 13F filing for Q3 2025, John Hussman's firm, Hussman Strategic Advisors, Inc., owns 63,000 shares of ADMA Biologics, Inc. (ADMA), valued at approximately $0. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
As of the Q3 2025 filing, ADMA Biologics, Inc. (ADMA) represents approximately 0.00% of John Hussman's publicly disclosed stock portfolio, making it one of their key holdings. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
John Hussman's peak holding in ADMA Biologics, Inc. (ADMA) was 105,000 shares, as reported at the end of Q1 2025. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.